• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2768554
  • February 2014
  • Region: Global
  • 68 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • GlySens Incorporated
  • Insulet Corporation
  • Medtronic, Inc.
  • MORE

'Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others.

The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2013 to 2019.

Geographically, the continuous glucose monitoring market has been classified READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • GlySens Incorporated
  • Insulet Corporation
  • Medtronic, Inc.
  • MORE

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rise in diabetic population globally
3.2.2 Rise in demand for point of care testing (POCT)
3.3 Market Restraints
3.3.1 Unfavourable reimbursement policies
3.3.2 Calibration issues
3.4 Market Opportunities
3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
3.5 Porter's Five Forces Analysis for the Global Continuous Glucose Monitoring Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography

Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 – 2019 (USD Million)
4.1 Overview
4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
4.2 Guardian Real Time CGM System
4.2.1 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
4.3 FreeStyle Navigator
4.3.1 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
4.4 Dexcom Seven Plus CGM System
4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
4.5 Dexcom G4 Platinum
4.5.1 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
4.6 MiniMed Paradigm Revel/Veo System
4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Other CGM Systems Market, 2011 – 2019 (USD Million)

Chapter 5 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
7.2 Investing in research and development of technologically advanced products with added benefits
7.3 Emphasis on price control

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Bayer AG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Dexcom, Inc.
8.3.1 Company overview
8.3.2 Financial overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 GlySens Incorporated
8.4.1 Company overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.5 Insulet Corporation
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Medtronic, Inc.
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Development
8.7 Nova Biomedical Corporation
8.7.1 Company overview
8.7.2 Product portfolio
8.7.3 Business Strategies
8.7.4 Recent Developments
8.8 Senseonics, Incorporated
8.8.1 Company overview
8.8.2 Product portfolio
8.8.3 Business Strategies
8.8.4 Recent Developments

List of Figures

FIG. 1 Continuous Glucose Monitoring: Market Segmentation
FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
FIG. 3 Porter's Five Force Analysis: Global Continuous Glucose Monitoring Market
FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
FIG. 5 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
FIG. 6 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
FIG. 8 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
FIG. 10 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 18 Annual Revenue: Bayer AG., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenue: Dexcom, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenue: Insulet Corporation, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenue: Medtronic, Inc., 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
TABLE 4 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 – 2019 (USD Million)

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • GlySens Incorporated
  • Insulet Corporation
  • Medtronic, Inc.
  • MORE

The rapid rise in diabetic population across the globe has considerably increased the demand for effective diabetes management systems. Currently, blood glucose meters are widely used for diabetes management; however, the trend is shifting towards minimally invasive (CGMS) or noninvasive glucose monitoring systems as these systems reduce the need for regular finger pricking and also lessen the pain. Continuous glucose monitoring systems are real time glucose sensing and monitoring devices that measure and display glucose levels of a patient at regular intervals.

The usage of CGM is substantially increasing over traditional glucose monitoring systems as these systems are user friendly, provide access to real time values and trend, and provide enhanced accuracy. Additionally, it has been observed that continuous glucose monitoring significantly helps in diabetes management especially in type I diabetics, and helps in reducing long-term complications associated with diabetes. Increasing awareness in developed and developing economies, technological advancements and rising number of diabetic patients are some of the key factors that are expected to fuel the growth of this market.

According to International Diabetes Federation (IDF) reports, approximately 382 million people globally were diagnosed with diabetes in 2013 and this number is expected to grow to 592 million by 2035. Additionally, as per Juvenile Diabetes Research Foundation (JDRF), the prevalence of type I diabetes rose by 23% in the U.S. between 2001 and 2009 for children under 20 years of age and is identified as the seventh leading cause of death in the country. Hence, rising number of patients suffering from type I diabetes is likely to increase the demand for CGMS.

The continuous glucose monitoring market has been segmented on the basis of various CGM systems available in the market including Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum and MiniMed Paradigm Revel/Veo CGM Systems. In 2012, the market for Guardian Real Time CGM system held the largest share globally, followed by Dexcom Seven Plus CGM system. However, during the forecast period 2013 to 2019, growth of the market for Guardian Real Time CGM system is expected to be slowest due to market saturation and development of innovative competitor products. Dexcom G4 Platinum CGM System market is expected to witness the fastest growth during the forecast period. FreeStyle Navigator that witnessed a decline in its market share in 2012 due to product recall from the U.S. market is anticipated to show significant growth during the forecast period due to expected launch of FreeStyle Navigator ll in 2014 in the U.S. market.

North America held the largest share in the global continuous glucose monitoring market in terms of revenue in 2012. Factors responsible for the leading position of this region were rising obesity population, aging population and increasing acceptance of technologically advanced devices. Europe held the second largest market in 2012, followed by Asia-Pacific. The Asia-Pacific region is expected to show the highest CAGR during the forecast period because of the presence of growing patient awareness, economic development and changing lifestyle. Other factors such as increasing healthcare expenditure, increasing market penetration by CGM players in this region are anticipated to increase the uptake of these devices in this region.

Medtronic, Inc., Dexcom, Inc., Abbott Diabetes Care, Inc., Bayer AG, Nova Biomedical Corporation, Senseonics, Incorporated, GlySens, Incorporated and Insulet Corporation are the major companies engaged in the development and commercialization of the continuous glucose monitoring systems. Presence of very few players in the CGM market provides ample opportunity for further research and development for both existing and emerging players.

- Abbott Laboratories
- Bayer AG
- Dexcom, Inc.
- GlySens Incorporated
- Insulet Corporation
- Medtronic, Inc.
- Nova Biomedical Corporation
- Senseonics, Incorporated

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos